SMLR
Semler Scientific, Inc.Company Information
- Company Name
- Semler Scientific, Inc.
- CIK
- CIK0001554859
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- SMLR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- SMLR
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-07
- Last sale
- 2025-11-17
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 124,010
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 10,609,370
- Shares outstanding
- 14,848,408
- Ownership
- 71.45%
Earnings Market Reaction
- Filing date
- 2025-11-12
- Price on filing date
- —
- 1-month reaction
- -27.44%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 13 | 10 | 9 | 7 | 7 | 63 | 57 | 37 | 39 | 5 | 23 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | 19 | 12 | 38 | 20 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Deposits Assets Current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 3 | 3 | 3 | 4 | 7 | 7 | 6 | 6 | 6 | 6 | 9 | 4 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | 6 | 6 | 6 | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 5 | 5 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 1 | ||||||
| Assets Current | 54 | 22 | 18 | 23 | 21 | 24 | 72 | 66 | 64 | 61 | 56 | 49 | ||||||
| Property Subject To Or Available For Operating Lease Net | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | ||||||
| Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Notes And Loans Receivable Net Noncurrent | 1 | 2 | 2 | - | - | - | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Crypto Asset Fair Value Noncurrent | 540 | 497 | 264 | 215 | 64 | 55 | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 | 3 | ||||||
| Deferred Income Tax Assets Net | - | - | 8 | - | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Assets | 597 | 523 | 293 | 240 | 92 | 85 | 84 | 78 | 79 | 75 | 70 | 63 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | ||||||
| Accrued Liabilities Current | 6 | 6 | 4 | 5 | 5 | 5 | 4 | 5 | 7 | 8 | 7 | 5 | ||||||
| Loss Contingency Accrual Carrying Value Current | - | 30 | 30 | - | - | - | - | - | - | - | - | - | ||||||
| Contract With Customer Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Short Term Borrowings | 20 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 27 | 37 | 36 | 6 | 7 | 6 | 6 | 6 | 9 | 10 | 9 | 7 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Other Liabilities Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Liabilities Net | 13 | 6 | - | 3 | - | - | - | - | - | - | - | - | ||||||
| Convertible Debt Noncurrent | 96 | 96 | 96 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 110 | 102 | 96 | 3 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 340 | 280 | 126 | 130 | 14 | 13 | 12 | 12 | 15 | 15 | 17 | 16 | ||||||
| Retained Earnings Accumulated Deficit | 120 | 103 | 36 | 101 | 71 | 66 | 66 | 60 | 56 | 50 | 44 | 39 | ||||||
| Stockholders Equity | 460 | 383 | 162 | 231 | 85 | 78 | 78 | 72 | 71 | 65 | 61 | 56 | ||||||
| Liabilities And Stockholders Equity | 597 | 523 | 293 | 240 | 92 | 85 | 84 | 78 | 79 | 75 | 70 | 63 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Receivable Fair Value Disclosure | - | - | - | - | - | - | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Deferred Tax Assets Valuation Allowance | - | - | - | - | 1 | 1 | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 15 | 14 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Shares Outstanding | 15 | 14 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSemler Scientific, Inc. (SMLR) — SEC Financial Statements & Analysis
Semler Scientific, Inc. (SMLR) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Semler Scientific, Inc. trades on Nasdaq as: SMLR. Semler Scientific, Inc. (SMLR)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12. Based on that filing, On profitability, Semler Scientific, Inc. posts a gross margin of 90.76%, an operating margin of -94.71%, a net margin of 130.80%, a Return on Equity (ROE) of 17.74%, a Return on Assets (ROA) of 14.03%, and a Return on Invested Capital (ROIC) of -8.43%. Per share, it reports EPS of $3.26, diluted EPS of $2.92, free cash flow per share of $-1.81, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -37.29% year-over-year, net income growth of 203.75% year-over-year, and EPS growth of 44.12% year-over-year. On the balance sheet, it maintains a current ratio of 1.97x, a quick ratio of 1.80x, working capital of $26.29M, a debt-to-equity ratio of 0.30x, a debt ratio of 0.23, an interest coverage ratio of -9.56x, free cash flow of $-26.93M (TTM), and net debt of $106.11M. Figures sourced from SEC EDGAR.
- EPS TTM
- $3.26
- ROE TTM
- 17.74%
- ROA TTM
- 14.03%
- Debt To Equity
- 0.30x
- Free Cash Flow TTM
- $-26.93M
- Net Revenue TTM Growth 1Y
- -37.29%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Semler Scientific, Inc. in?
Semler Scientific, Inc. (SMLR) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does SMLR trade on?
Semler Scientific, Inc. (SMLR) trades on the Nasdaq.
Where is Semler Scientific, Inc. incorporated?
Semler Scientific, Inc. is incorporated in DE.
When was Semler Scientific, Inc. (SMLR)'s most recent SEC filing?
Semler Scientific, Inc. (SMLR)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12.
What is SMLR's EPS (earnings per share)?
Semler Scientific, Inc. (SMLR)'s trailing twelve month EPS is $3.26 as of 2025-09-30.
What is SMLR's ROE (return on equity)?
Semler Scientific, Inc. (SMLR)'s trailing twelve month Return on Equity (ROE) is 17.74% as of 2025-09-30.
What is SMLR's ROA (return on assets)?
Semler Scientific, Inc. (SMLR)'s trailing twelve month Return on Assets (ROA) is 14.03% as of 2025-09-30.
What is SMLR's ROIC (return on invested capital)?
Semler Scientific, Inc. (SMLR)'s trailing twelve month Return on Invested Capital (ROIC) is -8.43% as of 2025-09-30.